Completed NA NCT00002076
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Sponsor: Pfizer
Conditions
HIV Infections Meningitis, Cryptococcal
Interventions
Fluconazole
Updated 5 times since 2017 Last updated: Jun 23, 2005
This NA trial investigates HIV Infections and Meningitis, Cryptococcal and is currently completed. Pfizer leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Pfizer
Data source: NIH AIDS Clinical Trials Information Service
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • New York, United States
- • Oakland, United States
- • Philadelphia, United States